Concepedia

Benjamin Lyons

BL

9

Publications

1.2K

Citations

9

H-Index

2003

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Johnson & Johnson (United States)

Pinnacle Oncology Hematology

Benjamin Lyons is an author at Memorial Sloan Kettering Cancer Center specializing in mood disorders, clinical psychiatry, and medicine.

Top concepts

Publications per year

2003–2018

9

Publications

9

Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy

F. Stephen Hodi, Marcus Ballinger, Benjamin Lyons et al. · Journal of Clinical Oncology · 2018 · 361 citations

Clinical Activity of Pertuzumab (rhuMAb 2C4), a HER Dimerization Inhibitor, in Advanced Ovarian Cancer: Potential Predictive Relationship With Tumor HER2 Activation Status

Michael S. Gordon, Daniela Matei, Carol Aghajanian et al. · Journal of Clinical Oncology · 2006 · 249 citations

Risperidone in the treatment of acute mania

Sumant Khanna, Eduard Vieta, Benjamin Lyons et al. · The British Journal of Psychiatry · 2005 · 188 citations · Full text

Efficacy and Safety of Single-Agent Pertuzumab (rhuMAb 2C4), a Human Epidermal Growth Factor Receptor Dimerization Inhibitor, in Castration-Resistant Prostate Cancer After Progression From Taxane-Based Therapy

David B. Agus, Christopher J. Sweeney, Michael J. Morris et al. · Journal of Clinical Oncology · 2007 · 103 citations · Full text

Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone

Peter Paul De Deyn, Ira R. Katz, Henry Brodaty et al. · Clinical Neurology and Neurosurgery · 2005 · 102 citations

, , +13

Rows per page

1–5 of 9